Lilly Asia Ventures
Darren Ji, M.D., Ph.D., is a Venture Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, Darren was Vice President and Global Head of Roche partnering in Asia and emerging markets; prior to that, he was co-founder and CEO of PharmaLegacy Laboratories and Director of Bioscience Business Development at P&G. Darren has over 20 year experience of pharmaceutical R&D and business development industry and holds a Ph.D. in molecular biology & biotechnology from University of Sheffield, an M.B.A. from University of Chicago, and an M.D. from China Medical University.
This person is not in the org chart
This person is not in any offices
Lilly Asia Ventures
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Originated in 2008 as a corporate venture subsidiary of Eli Lilly, they spun off and became an independent investment management company. As one of the earliest biomedical venture investors in China, they have been consistently investing in the region for over a decade, and have recently increased our footprint in the U.S. Our team of over 30 distinguished scientific, medical, investment, and operational professionals embrace a culture of integrity, entrepreneurship, and team work. Currently, they manage over $1.2 billion of committed capital.